epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Caziant
    desogestrel/ ethinyl estradiol
  • remove Depo-Estradiol
    estradiol cypionate
  • remove Zubsolv
    buprenorphine/ naloxone

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Caziant (desogestrel/ ethinyl estradiol) + Depo-Estradiol (estradiol cypionate)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + estradiol (hormone replacement)

avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx


desogestrel (contraceptive) + estradiol (hormone replacement)

monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

Additional Considerations

Smiley face Smiley face buprenorphine in Zubsolv

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

Smiley face Smiley face naloxone (abuse deterrent) in Zubsolv

no pharmacologic activity when administered as directed

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information